每年研究成果
每年研究成果
- 3結果
搜尋結果
-
2020
Author Correction: Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation (Scientific Reports, (2019), 9, 1, (4606), 10.1038/s41598-019-40757-6)
Chang, C. C., Huang, K. H., Hsu, S. P., Lee, Y. C. G., Sue, Y. M. & Juan, S. H., 12月 1 2020, 於: Scientific Reports. 10, 1, 12526.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2018
Corrigendum to ’ Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.’: [European Journal of Pharmacology 700 (2013) 65-73] (S0014299912010345) (10.1016/j.ejphar.2012.12.017))
Chen, C. H., Cheng, C. Y., Chen, Y. C., Sue, Y. M., Hsu, Y. H., Tsai, W. L. & Chen, T. H., 1月 15 2018, 於: European Journal of Pharmacology. 819, 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
-
2016
Corrigendum to: “Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation” (European Journal of Pharmacology (2012) 689(1–3) (65–71) (S0014299912005201) (10.1016/j.ejphar.2012.06.008))
Hsu, Y-H., Cheng, C-Y., Chen, Y. C., Chen, T-H., Sue, Y-M., Tsai, W. L. & Chen, C-H., 12月 5 2016, 於: European Journal of Pharmacology. 792, p. 79 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審